Moldova - román - ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)

vitafort, ungaria - monofosfat - premix - iepuri

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sc swiss pharm import-export srl -

Európai Unió - román - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - agenți antineoplazici - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bieffe medital s.p.a. - italia - combinatii - sol. pt. hemodializa/hemofiltrare - solutii pentru hemodializa si hemofiltrare solutii pentru hemofiltrare

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bieffe medital s.p.a. - italia - combinatii - sol. pt. hemodializa/hemofiltrare - solutii pentru hemodializa si hemofiltrare solutii pentru hemofiltrare

Európai Unió - román - EMA (European Medicines Agency)

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - toate celelalte produse terapeutice - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

synthon hispania s.l. - spania - sevelamer - compr. film. - 800mg - alte preparate terapeutice preparate pt. tratamentul hiperkalemiei si hiperfosfatemiei

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

heaton k.s. - republica ceha - sevelamer - compr. film. - 800mg - alte preparate terapeutice preparate pt. tratamentul hiperkalemiei si hiperfosfatemiei

Európai Unió - román - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - medicamente pentru tratamentul bolilor osoase - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Románia - román - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

synthon hispania s.l. - spania - sevelamer - compr. film. - 800mg - alte preparate terapeutice preparate pt. tratamentul hiperkalemiei si hiperfosfatemiei